SARS-CoV-2 BA.2.86 (“Pirola”): Is it Pi or Just Another Omicron Sublineage?

SARS-CoV-2 BA.2.86 (“Pirola”): Is it Pi or Just Another Omicron Sublineage?

The SARS-CoV-2 sublineage BA [...]

Bibliographic Details
Main Authors:	Daniele Focosi, Pietro Giorgio Spezia, Fabrizio Maggi
Format:	Article
Language:	English
Published:	MDPI AG 2023-10-01
Series:	Vaccines
Subjects:	n/a
Online Access:	https://www.mdpi.com/2076-393X/11/11/1634

Similar Items

Less neutralization evasion of SARS-CoV-2 BA.2.86 than XBB sublineages and CH.1.1
by: Yanping Hu, et al.
Published: (2023-12-01)

SARS-CoV-2 Omicron subvariant BA.2.86: limited potential for global spread
by: Xinling Wang, et al.
Published: (2023-11-01)

First sequenced cases of Omicron BA.2 sublineage in Ecuador
by: D.A. Andrade-Molina, et al.
Published: (2023-09-01)

Detection of SARS-CoV-2 BA.2.86 by lateral flow devices
by: Abbie Bown, et al.
Published: (2024-02-01)

Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant
by: Khadija Khan, et al.
Published: (2023-12-01)

Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion
by: Delphine Planas, et al.
Published: (2024-03-01)

The SARS-CoV-2 BA.2.86 subvariant: A new challenge in the ongoing pandemic
by: Prakasini Satapathy, et al.
Published: (2024-01-01)

Emergence of omicron variant's sublineages BA.4 and BA.5: risks assessment and possible countermeasures
by: Manish Dhawan, et al.
Published: (2022-07-01)

Rise of the BQ.1.1.37 SARS-CoV-2 Sublineage, Italy
by: Daniele Focosi, et al.
Published: (2023-03-01)

Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2
by: Qian Wang, et al.
Published: (2023-11-01)

Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2
by: Lia Fiaschi, et al.
Published: (2022-06-01)

The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5Research in context
by: Huiping Shuai, et al.
Published: (2023-09-01)

The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86
by: Daming Zhou, et al.
Published: (2024-03-01)

Evolution of SARS-CoV-2 from BA.2.86 to JN.1 variations and detection in Bangladesh
by: Roney, Miah, et al.
Published: (2024)

COVID-19 Pneumonia in Fully Vaccinated Adults during the Dominance of the Omicron Sublineages BA.1.1 and BA.2 in Mexico
by: Efrén Murillo-Zamora, et al.
Published: (2022-08-01)

Classification of Omicron BA.1, BA.1.1, and BA.2 sublineages by TaqMan assay consistent with whole genome analysis data
by: Yosuke Hirotsu, et al.
Published: (2022-09-01)

Continued Complexity of Mutations in Omicron Sublineages
by: Austin N. Spratt, et al.
Published: (2022-10-01)

Seroepidemiology of SARS-CoV-2 Virus in Healthcare Workers before Circulation of the Omicron Sublineages BA.4/BA.5 in Vojvodina, Serbia
by: Mioljub Ristić, et al.
Published: (2022-12-01)

Fusogenicity of SARS-CoV-2 BA.2.86 subvariant and its sensitivity to the prokaryotic recombinant EK1 peptide
by: Lijue Wang, et al.
Published: (2024-01-01)

Introduction and Rapid Spread of SARS-CoV-2 Omicron Variant and Dynamics of BA.1 and BA.1.1 Sublineages, Finland, December 2021
by: Hanna Vauhkonen, et al.
Published: (2022-06-01)

Cross-Reactivity Assessment of Vaccine-Derived SARS-CoV-2 T Cell Responses against BA.2.86 and JN.1
by: Muhammad Saqib Sohail, et al.
Published: (2024-03-01)

Discrimination of SARS-CoV-2 Omicron Sublineages BA.1 and BA.2 Using a High-Resolution Melting-Based Assay: a Pilot Study
by: Akira Aoki, et al.
Published: (2022-08-01)

Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by three doses of BNT162b2 vaccine or BA.1 infection
by: Chaitanya Kurhade, et al.
Published: (2022-12-01)

Analysis of SARS-CoV-2 sublineages reported from local cases in mainland China (September 2022-January 2023) and surveillance of outbound passengers.
by: Daniele Focosi, et al.
Published: (2023-06-01)

Cross-neutralization and viral fitness of SARS-CoV-2 Omicron sublineages
by: Hongjie Xia, et al.
Published: (2023-12-01)

The Era of the FLips: How Spike Mutations L455F and F456L (and A475V) Are Shaping SARS-CoV-2 Evolution
by: Daniele Focosi, et al.
Published: (2023-12-01)

Omicron BA.2.75 Sublineage (Centaurus) Follows the Expectations of the Evolution Theory: Less Negative Gibbs Energy of Biosynthesis Indicates Decreased Pathogenicity
by: Marko Popovic
Published: (2022-11-01)

Omicron BA.1 breakthrough infections in inactivated COVID-19 vaccine recipients induced distinct pattern of antibody and T cell responses to different Omicron sublineages
by: Li Guo, et al.
Published: (2023-12-01)

Variant pirola has not spread in Malaysia; experts - Malaysians still need to be careful
by: Guang Ming Daily
Published: (2023)

Neutralization against Omicron sublineages (BA.2/BA.5/BQ.1.1/XBB/XBB.1.5) in bivalent BNT162b2-vaccinated HCWs with or without risk factors, or following BT infection with Omicron
by: Masayuki Amano, et al.
Published: (2023-10-01)

Variation of Proteolytic Cleavage Sites towards the N-Terminal End of the S2 Subunit of the Novel SARS-CoV-2 Omicron Sublineage BA.2.12.1
by: Nadine Anna Schilling, et al.
Published: (2022-09-01)

An mRNA vaccine with broad-spectrum neutralizing protection against Omicron variant sublineages BA.4/5 -included SARS-CoV-2
by: Ye Sang, et al.
Published: (2022-10-01)

Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages
by: Shuai Xia, et al.
Published: (2022-07-01)

Rapid emergence of omicron sublineages expressing spike protein R346T
by: Ramona Groenheit, et al.
Published: (2023-01-01)

Do We Really Need Omicron Spike-Based Updated COVID-19 Vaccines? Evidence and Pipeline
by: Daniele Focosi, et al.
Published: (2022-11-01)

BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
by: Annika Rössler, et al.
Published: (2022-12-01)

Diversity of Omicron sublineages and clinical characteristics in hospitalized patients in the southernmost state of Brazil
by: Jaqueline Rhoden, et al.
Published: (2024-02-01)

Severity and outcomes of Omicron variant of SARS-CoV-2 compared to Delta variant and severity of Omicron sublineages: a systematic review and metanalysis
by: Lisa Askie, et al.
Published: (2023-07-01)

Observation of a new D-s meson decaying to DK at a mass of 2.86 GeV/c(2)
by: Aubert, B, et al.
Published: (2006)

Antigenicity comparison of SARS‐CoV‐2 Omicron sublineages with other variants contained multiple mutations in RBD
by: Qianqian Li, et al.
Published: (2022-06-01)